全文获取类型
收费全文 | 102245篇 |
免费 | 5269篇 |
国内免费 | 5049篇 |
专业分类
耳鼻咽喉 | 680篇 |
儿科学 | 1893篇 |
妇产科学 | 2309篇 |
基础医学 | 8925篇 |
口腔科学 | 2602篇 |
临床医学 | 10712篇 |
内科学 | 14885篇 |
皮肤病学 | 727篇 |
神经病学 | 3473篇 |
特种医学 | 5056篇 |
外国民族医学 | 26篇 |
外科学 | 7991篇 |
综合类 | 20373篇 |
现状与发展 | 5篇 |
一般理论 | 28篇 |
预防医学 | 10319篇 |
眼科学 | 2020篇 |
药学 | 8069篇 |
17篇 | |
中国医学 | 6764篇 |
肿瘤学 | 5689篇 |
出版年
2024年 | 109篇 |
2023年 | 588篇 |
2022年 | 1294篇 |
2021年 | 1638篇 |
2020年 | 1305篇 |
2019年 | 1081篇 |
2018年 | 1350篇 |
2017年 | 1168篇 |
2016年 | 1261篇 |
2015年 | 1727篇 |
2014年 | 2154篇 |
2013年 | 2310篇 |
2012年 | 3742篇 |
2011年 | 6944篇 |
2010年 | 4230篇 |
2009年 | 3038篇 |
2008年 | 4007篇 |
2007年 | 3798篇 |
2006年 | 3909篇 |
2005年 | 4882篇 |
2004年 | 9488篇 |
2003年 | 8817篇 |
2002年 | 7069篇 |
2001年 | 5410篇 |
2000年 | 3555篇 |
1999年 | 4314篇 |
1998年 | 3024篇 |
1997年 | 2767篇 |
1996年 | 1822篇 |
1995年 | 1629篇 |
1994年 | 1592篇 |
1993年 | 2364篇 |
1992年 | 1969篇 |
1991年 | 1641篇 |
1990年 | 1271篇 |
1989年 | 1037篇 |
1988年 | 809篇 |
1987年 | 682篇 |
1986年 | 648篇 |
1985年 | 383篇 |
1984年 | 226篇 |
1983年 | 138篇 |
1982年 | 111篇 |
1981年 | 105篇 |
1980年 | 78篇 |
1979年 | 99篇 |
1978年 | 70篇 |
1977年 | 82篇 |
1974年 | 65篇 |
1973年 | 69篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Yinlei
Wen Huaguang Zhang Hanguang Su He Ren 《Optimal control applications & methods.》2020,41(4):1233-1250
In this article, a model-free off-policy reinforcement learning algorithm is applied to address the optimal tracking problem based on multiplayer non-zero-sum games for discrete-time linear systems. In contrast to the traditional method and the policy iteration method for solving the optimal tracking problems, the proposed algorithm operates with the system data rather than the knowledge of the system dynamics. For performing the proposed algorithm, an auxiliary augmented system is constructed via assembling the original system and the reference trajectory while a discount factor is introduced into the performance indexes. It is analyzed that the solutions of the proposed algorithm converge to the Nash equilibrium and the result is not influenced by the probing noise. Two simulations are presented to verify the feasibility and effectiveness of the proposed algorithm. 相似文献
2.
Platelet function has been described by many laboratory assays, and PL-11 is a new point-of-care platelet function analyzer based on platelet count drop method, which counts platelet before and after the addition of agonists in the citrated whole blood samples. The present study sought to compare PL-11 with other three major more established assays, light transmission aggregometry (LTA), VerifyNow? aspirin system and thromboelastography (TEG), for monitoring the short-term aspirin responses in healthy individuals. Ten healthy young men took 100?mg/d aspirin for 3-day treatment. Platelet function was measured via PL-11, LTA, VerifyNow and TEG, respectively. The blood samples were collected at baseline, 2 hour, 1 day during the aspirin treatment and 1 day, 5?±?1 days, 8?±?1 days after the aspirin withdrawal. Moreover, 90 additional healthy subjects were recruited to establish a reference range for PL-11. Platelet function of healthy subjects decreased significantly 2 hours after 100?mg/d aspirin intake and began to recover during 4–6 days after the aspirin withdrawal. Correlations between methods were PL-11 vs. LTA (r?=?0.614, p?<?0.01); PL-11 vs. VerifyNow (r?=?0.829, p?<?0.01); PL-11 vs. TEG (r?=?0.697, p?<?0.001). There was no significant bias between PL-11 and LTA at baseline (bias?=?1.94%, p?=?0.804) using Bland-Altman analysis, while the data of PL-11 were significantly higher than LTA (bias?=?24.02%, p?<?0.001) during the aspirin therapy. The reference range for PL-11 in healthy young individuals was from 66.8 to 90.5% (95%CI). When aspirin low-responsiveness was defined as LTA?>?20%, the cut-off values for each method were, respectively: PL-11?>?50%, VerifyNow?>?533 ARU, TEG?>?60.2%. The results of different platelet function assays were uninterchangeable for monitoring aspirin response and correlations among them were also varied. Correlations among PL-11 and other three major assays suggested the ability of PL-11 to assess the treatment effects of aspirin. But a large cohort study is needed to confirm the cut-off value of aspirin response detected by PL-11. 相似文献
3.
4.
中华医学会器官移植学分会 《中华移植杂志(电子版)》2020,14(3):136-142
儿童心脏移植是治疗年龄18岁终末期心力衰竭患者的有效手段。1967年美国Adrian Katrowitz实施第一例儿童心脏移植,近五年全球80家单位每年开展500例左右。中国儿童心脏移植起步晚、发展慢。自1995年开展第一例儿童心脏移植以来,目前国内已登记病例超过130例。中华医学会器官移植学分会组织心脏移植专家,总结国内外相关研究最新进展,结合国际指南和临床实践,针对儿童心脏移植受者选择及常用术式的操作要点、程序和方法,以及各类复杂先天性心脏病心脏移植的特殊操作,制订《中国儿童心脏移植适操作规范(2019版)》。 相似文献
5.
Annals of Nuclear Medicine - Cardiac amyloidosis is a rare disease characterized by amyloid heart deposits and is usually a part of systemic amyloidosis, in relation to systemic light chain (AL)... 相似文献
6.
Journal of Chinese Pharmaceutical Sciences 《中国药学》2019,28(12):889-901
7.
Wei Zhang Zheng Li Feng-Qing Xu Ya-Shuo Ren Shuang-Wang Xu Tong-Sheng Wang 《Journal of Asian natural products research》2019,21(5):426-434
Two new 11-methoxyl substituted triterpenoids, named as mimengosides J (1) and K (2), along with seven known compounds, were isolated from the fruits of Buddleja lindleyana. Their structures were elucidated on the basis of spectroscopic analysis. In addition, the new ones were evaluated for protective effects against damage of SH-SY5Y cells induced by 1-methyl-4-phenylpyridinium ion (MPP+) and the results indicated that those may be one of the candidate compositions of Buddleja lindleyana for the treatment of neurodegenerative disease.
8.
9.
10.
L. Misery E. Weisshaar E. Brenaut A.W.M. Evers F. Huet S. Ständer A. Reich E. Berardesca E. Serra-Baldrich J. Wallengren D. Linder J.W. Fluhr J.C. Szepietowski H. Maibach for the Special Interest Group on sensitive skin of the International Forum for the Study of Itch 《Journal of the European Academy of Dermatology and Venereology》2020,34(2):222-229
The special interest group on sensitive skin of the International Forum for the Study of Itch previously defined sensitive skin as a syndrome defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus and tingling sensations) in response to stimuli that normally should not provoke such sensations. This additional paper focuses on the pathophysiology and the management of sensitive skin. Sensitive skin is not an immunological disorder but is related to alterations of the skin nervous system. Skin barrier abnormalities are frequently associated, but there is no cause and direct relationship. Further studies are needed to better understand the pathophysiology of sensitive skin – as well as the inducing factors. Avoidance of possible triggering factors and the use of well-tolerated cosmetics, especially those containing inhibitors of unpleasant sensations, might be suggested for patients with sensitive skin. The role of psychosocial factors, such as stress or negative expectations, might be relevant for subgroups of patients. To date, there is no clinical trial supporting the use of topical or systemic drugs in sensitive skin. The published data are not sufficient to reach a consensus on sensitive skin management. In general, patients with sensitive skin require a personalized approach, taking into account various biomedical, neural and psychosocial factors affecting sensitive skin. 相似文献